Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension

Authors :: Monica Mukherjee
Roham T. Zamanian
Reda E. Girgis
Valentina Mercurio
Paul M. Hassoun
Kelly Chin
Stephen C. Mathai
Rubina M. Khair
Takahiro Sato
Ryan J. Tedford
Omar A. Minai
Todd M. Kolb
Rachel L. Damico
Fernando Torres
Mercurio, Valentina
Mukherjee, Monica
Tedford, Ryan J
Zamanian, Roham T
Khair, Rubina M
Sato, Takahiro
Minai, Omar A
Torres, Fernando
Girgis, Reda E
Chin, Kelly
Damico, Rachel
Kolb, Todd M
Mathai, Stephen C
Hassoun, Paul M
Source :: American journal of respiratory and critical care medicine. 197(3)
Publication Year :: 2017

Subjects :: Male
Ventricular Dysfunction, Right
Phenylpropionate
Strain (injury)
030204 cardiovascular system & hematology
Critical Care and Intensive Care Medicine
Scleroderma
Tadalafil
Cohort Studies
0302 clinical medicine
Prospective Studies
Prospective cohort study
Associated Pulmonary Arterial Hypertension
Observer Variation
Phenylpropionates
Middle Aged
Pyridazines
Treatment Outcome
Anesthesia
Cardiology
Drug Therapy, Combination
Female
Pyridazine
medicine.drug
Human
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Ambrisentan
Hypertension, Pulmonary
Magnetic Resonance Imaging, Cine
Drug Administration Schedule
Follow-Up Studie
03 medical and health sciences
Pharmacotherapy
Scleroderma, Limited
Internal medicine
Correspondence
medicine
Humans
Aged
Dose-Response Relationship, Drug
business.industry
medicine.disease
Pulmonary hypertension
Myocardial Contraction
Prospective Studie
030228 respiratory system
Cohort Studie
business
Follow-Up Studies

Tools